A5046419586- Health Systems, Economic Evaluations, Quality of Life
- Biosimilars and Bioanalytical Methods
- Human-Animal Interaction Studies
- Neuroendocrine regulation and behavior
- Biomedical Ethics and Regulation
- Clinical practice guidelines implementation
Institute of Science and Technology Austria
2021
While high risk of failure is an inherent part developing innovative therapies, it can be reduced by adherence to evidence-based rigorous research practices. Supported through the European Union’s Innovative Medicines Initiative, EQIPD consortium has developed a novel preclinical quality system that applied in both public and private sectors free for anyone use. The Quality System was designed suited boost innovation ensuring generation robust reliable data while being lean, effective not...
Science & Society4 November 2021Open Access Towards best practices in research Role of academic core facilities Leonardo Restivo Corresponding Author [email protected] orcid.org/0000-0002-3709-5504 Neuro-BAU, Department Fundamental Neuroscience, Faculty Biology Medicine, University Lausanne, Switzerland These authors contributed equally to this work Search for more papers by author Björn Gerlach orcid.org/0000-0002-4900-6302 PAASP GmbH, Heidelberg, Germany Michael Tsoory...